Newsletter Subscription


Friday, July 29, 2016


Implant Sciences QS-B220 Trace Detection System Gains Further Traction in the European Airport Security Market

Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has sold its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector to a new customer in Europe. The unit will be used for airport security at a major international airport in Europe.

"Designed to meet the requirements of aviation security professionals, our desktop trace detector is gaining increasing acceptance and traction in global markets. As we continue to grow our distribution channel, we look forward to demonstrating its advantages in increasing numbers of procurements," stated Implant Sciences' President and CEO, Glenn D. Bolduc.


Related Research on ASDReports.com:
Global Military Laser Systems Market 2016-2020

"The QS-B220 provides an effective method for screening passengers without concerns about radiation and privacy. This and the ability to adapt the easy-to-use touch-screen interface to the local language were important factors in Implant Sciences winning this order from a new customer through a new distributor," added Dr. Darryl Jones, Implant Sciences' Vice President of Sales and Marketing.

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Implant Sciences Corp.

Published on ASDNews: Dec 10, 2012

 

International Security Cooperation Summit

Aug 29 - 31, 2016 - Clearwater Beach, United States

Register More info


Engine Leasing Seminar 2016

Sep 19, 2016 - London, United Kingdom

Register More info


Smarter Borders 2016 Conference

Nov 21 - 23, 2016 - London, United Kingdom

Register More info


© 2004-2016 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk